Development of new drugs to treat diseases other than the novel coronavirus looks set to be delayed as the outbreak…...
Please subscribe to read the full story.
Astellas Pharma
Astellas to Acquire US Gene Therapy Venture Audentes
Astellas Pharma Inc. (TYO:4503) recently announced that it has agreed to acquire Audentes Therapeutics Inc., a U.S.-based venture specializing in…...
Please subscribe to read the full story.
Industry Outlook 2017: Pharmaceuticals Part 4 – Digital Health
The digital health field is garnering much attention within the pharmaceutical industry as a growth strategy. In concert with the…...
Please subscribe to read the full story.
